Fujian Cosunter Pharmaceutical Co Ltd
300436
Company Profile
Business description
Fujian Cosunter Pharmaceutical Co Ltd is a pharmaceutical company engaged in the pharmaceutical production, sales and Research and Development. Its specialized in the field of hepatitis B medicine. Its product includes Fuganding-tenofovir disoproxil fumarate capsule, Enganding-Entecavir Capsules, He Ganding-Lamifuzed tablets and Agandan-adefovir dipivoxil tablets.
Contact
Software Park, No. 89, Software Avenue
Block B, Building 10, Zone B
Gulou District, Fujian
Fuzhou350003
CHNT: +86 59138305333
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
760
Stocks News & Analysis
stocks
Coca-Cola earnings: Innovation and brand strength underpin growth
We plan to raise our fair value estimate of Coca-Cola stock.
stocks
Going into earnings, is Netflix stock a buy, a sell, or fairly valued?
Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,321.10 | 10.80 | -0.12% |
| CAC 40 | 8,229.49 | 29.37 | -0.36% |
| DAX 40 | 24,322.75 | 7.28 | -0.03% |
| Dow JONES (US) | 46,924.74 | 218.16 | 0.47% |
| FTSE 100 | 9,489.53 | 62.54 | 0.66% |
| HKSE | 25,807.71 | 219.84 | -0.84% |
| NASDAQ | 22,953.67 | 36.88 | -0.16% |
| Nikkei 225 | 49,307.79 | 8.27 | -0.02% |
| NZX 50 Index | 13,306.44 | 71.41 | -0.53% |
| S&P 500 | 6,735.35 | 0.22 | 0.00% |
| S&P/ASX 200 | 9,030.00 | 10.30 | -0.11% |
| SSE Composite Index | 3,913.76 | 2.57 | -0.07% |